Skip to content

Clinical trials

Completed Liver Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Status: Completed Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20091
20101
20131
20141
20152
20163
20182
20193
20202
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Continent Pharmaceutical Co, Ltd.1
Blueprint Medicines Corporation1
Chinese Medical Association1
Eastern Hepatobiliary Surgery Hospital1
First Affiliated Hospital of Wenzhou Medical University1
Hai Li1
Helio Genomics1
Hepatopancreatobiliary Surgery Institute of Gansu Province1
Imunon1
Jiangang Song1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases23
Carcinoma, Hepatocellular7
Liver Neoplasms5
Hepatitis B4
Digestive System Diseases3
Digestive System Neoplasms3
Hepatitis, Viral, Human3
Neoplasms3
Adenocarcinoma2
Hepatitis, Chronic2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.